Join ISPOR  | Sign up for mailing List  | Follow Us: LinkedIn Twitter Facebook YouTube
 
ISPOR Meetings
ISPOR 19th Annual International Meeting
May 31- June 4, 2014
Palais des Congrès de Montréal, Montreal, QC, Canada

Early Registration Deadline: April 15, 2014
Registration Cancellation Deadline: April 15, 2014
Edit Registration Deadline: May 6, 2014

 

View Registration Fees

Program | Symposia | Sponsorship | Exhibit Opportunities

Montreal, QC, Canada, May 2014
Register/Edit Registration
Edit Registration
ISPOR 6th Asia Pacific Conference
6-9 September 2014
Beijing International Convention Center, Beijing, China

Abstract Submission Deadline: 20 March 2014
Early Registration Deadline: 22 July 2014
Registration Cancellation Deadline: 22 July 2014
Edit Registration Deadline: 11 August 2014

View Registration Fees

Beijing, China
Register/Edit Registration
Edit Registration

ISPOR 17th Annual European Congress
8-12 November 2014
Amsterdam RAI, Amsterdam, The Netherlands

Abstract Submission Opens: 24 March 2014
Abstract Submission Deadline: 24 June 2014
Early Registration Deadline: 16 September 2014
Submit Abstract or Proposal

 

Symposia | Sponsorship | Exhibit Opportunities

Amsterdam Congress
Recent Meetings
ISPOR 16th Annual European Congress
2-6 November 2013
The Convention Centre Dublin, Dublin, Ireland

Congress featured over 1800 presentations!
Over 3800 attendees!

Released Presentations
Scientific Award Recipients
Photo Gallery
Dublin, Ireland
ISPOR 4th Latin American Conference
12-14 September 2013
Hilton Buenos Aires, Buenos Aires, Argentina

Conference featured over 400 presentations!
Over 740 Attendees!

Released Presentations
Scientific Award Recipients
Photo Gallery
Buenos Aires, Argentina
HIGHLIGHTS FOR THE MONTH

Educational Video Series on
Health Care Decisions

Michael Barry Health Technology Assessment of the New Cystic Fibrosis Drug (2013)
Michael Barry, MD, PhD, FRCPI, Clinical Director, National Centre for Pharmacoeconomics, St. James's Hospital, Dublin, Ireland
Leeza Osipenko, PhD NICE Scientific Advice: An HTA Agency Perspective
Leeza Osipenko, PhD, NICE, UK
Karl Claxton, PhD Issues in Using MCDA in Health Care Decisions
Karl Claxton, PhD
, University of York, UK

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2014 International Society for Pharmacoeconomics and Outcomes Research. All rights reserved under International and Pan-American Copyright Conventions. 
Website design by Eagle Systems USA, Inc.